Condition
Non-Small Cell Lung Cancer With EGFR Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Non-Small Cell Lung Cancer With EGFR Mutation clinical trials that are recruiting, at sites in 2 countries (most in China (3), Mexico (1)). By phase: Phase 1 (1), Phase 3 (1), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Non-Small Cell Lung Cancer With EGFR Mutation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combination therapy for advanced lung cancer with specific mutations | Phase 2 | Hefei, Anhui and 4 other locations | Recruiting | Oct 31, 2024 |
| CFT8919 in advanced EGFR-mutated NSCLC (phase I) | Phase 1 | Hangzhou, Zhejiang | Recruiting | Oct 15, 2024 |
| Combining GH21 Capsules with Osimertinib for Non-Small Cell Lung Cancer | Phase 1/2 | Hefei, Anhui and 5 other locations | Recruiting | Mar 12, 2024 |
| Glutamine and L. Reuteri to prevent diarrhea in lung cancer patients on TKI therapy | Phase 3 | Mexico City, Mexico City | Recruiting | May 10, 2023 |
All recruiting trials (4)
-
Combination therapy for advanced lung cancer with specific mutations
This study is testing a new combination of two drugs to see if they can help people with advanced lung cancer that has certain mutations feel better and live longer.
-
CFT8919 in advanced EGFR-mutated NSCLC (phase I)
This early phase study tests CFT8919 capsules to see if they are safe and tolerable and to get a sense of anti-tumor activity in patients with NSCLC driven by EGFR mutations.
-
Combining GH21 Capsules with Osimertinib for Non-Small Cell Lung Cancer
This study is testing if combining GH21 capsules with Osimertinib can help people with advanced Non-Small Cell Lung Cancer that has specific genetic changes.
-
Glutamine and L. Reuteri to prevent diarrhea in lung cancer patients on TKI therapy
This study is testing if adding glutamine and a probiotic called L. reuteri to the diet can help prevent diarrhea in lung cancer patients receiving TKI treatment.
Related topics
Quick answers
How many Non-Small Cell Lung Cancer With EGFR Mutation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.